| Literature DB >> 31367261 |
Xianyong Ma1,2,3,4,5, Li Wang1,2,3,4,5, Zibiao Shi1,2,3,4,5, Wei Chen1,2,3,4,5, Xuefen Yang1,2,3,4,5, Youjun Hu1,2,3,4,5, Chuntian Zheng1,2,3,4,5, Zongyong Jiang1,2,3,4,5.
Abstract
BACKGROUND: The mechanism of high ambient temperature affecting meat quality is not clear till now. This study investigated the effect of high ambient temperature on meat quality and nutrition metabolism in finishing pigs.Entities:
Keywords: Growth performance; High ambient temperature; Meat quality; Restricted feed intake; mRNA array
Year: 2019 PMID: 31367261 PMCID: PMC6657146 DOI: 10.1186/s12263-019-0643-9
Source DB: PubMed Journal: Genes Nutr ISSN: 1555-8932 Impact factor: 5.523
Primer sequences
| Target gene | Primer sequence (5′ to 3′) | Accession no. | Product size (bp) |
|---|---|---|---|
| Forward: CGCCTGTTCTGTCGTCTC | NM_001099931.1 | 263 | |
| Reverse: TCTCATCAAACTCCACTCCC | |||
| Forward: TGCCCAGGTAAGCGACAT | NM_214254.2 | 272 | |
| Reverse: TGCCAGCAGTAGTGGTAAGG | |||
| Forward: CCATGAATCCCCAGAACACT | NM_001123128.1 | 313 | |
| Reverse: ATGACGCCTGCATCCTTGGT | |||
| Forward: TTCTCACAACACTGACCCTCTT | EU164847 | 330 | |
| Reverse: GCCCTCCGACTCTAACCAC | |||
| Forward: CCCGAGACCCTGGAGAAAT | NM_214236.1 | 457 | |
| Reverse: CAACACTCAGAAGCAAACCCTAC | |||
| Forward: AATGAGAACAGCGAGCAA | AY448008.2 | 279 | |
| Reverse: TTCCGTCGTAGCGTGATA | |||
| Forward: ACCGAGTGCTGGTTGTGC | NM_001044550.1 | 305 | |
| Reverse: GTTGTTGGAGACCGTGGC | |||
| Forward: AAAGCCAACCAAGATAACCC | NM_213963.1 | 242 | |
| Reverse: TCACCAAATAGCCGCAGAC | |||
| Forward: CGACTGGATGGCGGTTG | NM_214286 | 271 | |
| Reverse: ATGCCCTACTGGTTTCTGGAT | |||
| Forward: CCCTCATCGACAGCCACTT | NM_001001863.1 | 318 | |
| Reverse: GCACCTTCTTCTTCATCTCCC | |||
| Forward: TGAACGACCTCCAGAAAGC | NM_213912.3 | 345 | |
| Reverse: GGCGGACACTCAGGAATAA | |||
| Forward: TAAAGCACAGAAAGGAGCAG | NM_001190232.2 | 217 | |
| Reverse: TCCAGTTGGGTCAAGACG | |||
| Forward: CCTCATCGGCGGTGTGGA | NM_004104 | 122 | |
| Reverse: TGAAGTCGAAGAAGAAGGAGAGC | |||
| Forward: ACAGCCTGCCCCAGGC | NM_001123158 | 148 | |
| Reverse: TTCAGCCTCTTGATGAC | |||
| Forward: GAGCGAAAGCATTTGCCAAG | AF102857 | 101 | |
| Reverse: GGCATCGTTTATGGTCGGAAC |
Effect of high temperature and feed restriction on growth performance and meat quality of finishing pigs
| Variable | Treatment | S.E.M | ||||
|---|---|---|---|---|---|---|
| 22AL | 22PF | 35AL | ||||
| (22 °C, ad lib) | (22 °C, pair-fed) | (35 °C, ad lib) | ||||
| Initial BW, kg | 77.75 | 77.62 | 77.80 | 0.416 | 0.630 | |
| Final BW, kg | 103.85 | 86.02 | 87.70 | 10.12 | < 0.001 | |
| ADG, kg/day | 0.87a | 0.28b | 0.33b | 0.061 | < 0.001 | |
| ADFI, kg/day | 3.02a | 1.68b | 1.51b | 0.146 | < 0.001 | |
| G:F | 0.29b | 0.17a | 0.22b | 0.015 | 0.001 | |
| Backfat first rib, mm Thickness tenth rib, mm Last rib, mm | 33.67a | 39.09b | 42.77b | 0.862 | 0.043 | |
| 21.48 | 22.04 | 22.27 | 0.974 | 0.715 | ||
| 14.05 | 17.63 | 18.85 | 0.315 | 0.057 | ||
| Loin eye area, mm2 | 4766 | 4431 | 4355 | 0.507 | 0.431 | |
| Leaf fat weight, kg | 0.525 | 0.534 | 0.586 | 0.442 | 0.373 | |
| pH | 45 min | 6.10b | 6.15ab | 6.20a | 0.04 | 0.113 |
| 24 h | 5.48b | 5.48b | 5.57a | 0.014 | 0.002 | |
| 48 h | 5.52b | 5.55ab | 5.64a | 0.022 | 0.053 | |
| Drip loss,% | 24 h | 2 | 2 | 2.05 | 0.095 | 0.977 |
| 48 h | 2.61 | 2.48 | 2.59 | 0.101 | 0.872 | |
| 45 min | 45.25b | 46.58a | 47.45a | 0.303 | < 0.001 | |
| 24 h | 57.87 | 58.19 | 58.11 | 0.415 | 0.926 | |
| 48 h | 57.75 | 58.18 | 58.87 | 0.386 | 0.082 | |
| 45 min | 15.84 | 15.58 | 15.81 | 0.203 | 0.864 | |
| 24 h | 15.39 | 14.67 | 14.42 | 0.147 | 0.511 | |
| 48 h | 15.12 | 15.55 | 15.06 | 0.210 | 0.612 | |
| 45 min | 2.31 | 2.61 | 2.59 | 0.112 | 0.503 | |
| 24 h | 3.98 | 3.4 | 3.62 | 0.142 | 0.269 | |
| 48 h | 3.11 | 3.16 | 3.23 | 0.167 | 0.96 | |
| IMF,% | 4.77a | 3.03b | 2.89b | 0.351 | 0.05 | |
| Shear force, | 41.51b | 49.01a | 43.15b | 1.127 | 0.038 | |
| Glycogen content, mg/g | 2.15a | 1.38b | 1.19b | 0.681 | 0.046 | |
Data are means with s.e.m., n = 8
a, b, Within a row, means with a common superscript do not differ (P > 0.05)
ADG average daily gain, ADFI average daily feed intake, F:G, feed gain ratio, IMF intramuscular fat, L* lightness, a redness, b yellowness
Fig. 1Differentially expressed genes in high temperature (35AL) vs. control (22AL), pair-fed (22PF) pigs vs. controls (22AL), high temperature (35AL) vs. pair-fed (22PF) pigs. a Volcano plot, red part stands for P value smaller than 0.05 and an average fold change (FC) of at least 2 in either direction. b Number of differentially expressed genes between treatments
Differentially expressed genes related to energy metabolism, muscle structure, and stress response
| Genea | Description | Fold changeb | ||
|---|---|---|---|---|
| 35AL vs. 22AL | 22PF vs. 22AL | 35AL vs. 22PF | ||
| Lipid metabolic process | ||||
| Acyl-CoA synthetase long-chain family member 1 | 0.22 | 0.45 | ||
| Integrin, alpha V | 0.25 | |||
| CD36 molecule | 0.28 | |||
| Fatty acid binding protein 3 | 0.42 | 0.46 | ||
| 0.22 | 0.29 | |||
| Carnitine palmitoyltransferase 1B | 0.48 | |||
| Lipoprotein lipase | 0.35 | |||
| Stearoyl-CoA desaturase | 0.18 | |||
| 2,4-Dienoyl CoA reductase 1, mitochondria | 0.24 | 0.50 | 0.50 | |
| Acyl-CoA dehydrogenase, long chain | 0.47 | 0.39 | ||
| Acyl-CoA dehydrogenase | 0.39 | 0.46 | ||
| Acyl-CoA oxidase 1, palmitoyl | 0.44 | |||
| Cytochrome P450, family 2, subfamily E, polypeptide 1 | 6.22 | 3.79 | ||
| ATP synthase, H+ transporting, mitochondrial F1 complex | 0.21 | 0.41 | ||
| Sus scrofa fatty acid synthase | 2.42 | |||
| Sus scrofa apolipoprotein C-III | 4.99 | 0.29 | ||
| Sus scrofa carnitine palmitoyltransferase 1A | 0.45 | |||
| Sus scrofa lipin 1 mRNA | 0.35 | 0.38 | 0.72 | |
| Sus scrofa peroxisome proliferator activated receptor gamma, coactivator 1 alpha (PPARGC-1) | 2.37 | |||
| Glucose metabolic process | ||||
| UDP-glucose pyrophosphorylase 2 | 0.16 | 0.40 | ||
| Glucose-6-phosphate isomerase | 0.20 | 0.34 | ||
| Glycerol-3-phosphate dehydrogenase 1 | 0.38 | 0.44 | ||
| Phosphofructokinase, muscle | 0.36 | 0.45 | ||
| Triosephosphate isomerase 1 | 0.15 | 0.23 | ||
| Pyruvate kinase, muscle | 0.14 | 0.23 | ||
| Phosphoglucomutase | 0.35 | 0.33 | ||
| Sus scrofa phosphoenolpyruvate carboxykinase 1 | 2.42 | 2.42 | ||
| Muscle structure development | ||||
| Soc-2 suppressor of clear homolog | 0.32 | 0.45 | ||
| Calsequestrin 1 (fast-twitch, skeletal muscle) | 0.46 | 0.46 | ||
| Myosin, heavy chain 4, skeletal muscle | 0.29 | 0.43 | ||
| Actin, alpha 1, skeletal muscle | 0.32 | 0.36 | ||
| Actin, alpha 2, smooth muscle, | 0.39 | 0.40 | ||
| Actin, alpha, cardiac muscle 1 | 0.435 | 0.26 | ||
| Bridging integrator 1 | 0.17 | 0.16 | ||
| High mobility group box 1 | 0.45 | 0.34 | ||
| Sarcoglycan, alpha | 0.25 | 0.40 | ||
| Integrin, beta 1 | 0.18 | 0.27 | ||
| Catenin (cadherin-associated protein), beta 1 | 0.38 | 0.49 | ||
| Myostatin | 0.41 | 1.14 | 0.36 | |
| Myosin IB | 0.349 | 0.42 | ||
| Protein phosphatase 3, catalytic subunit, beta isozyme | 0.18 | 0.28 | ||
| Caveolin 2 | 0.25 | 0.45 | ||
| Tropomyosin 2 (beta) | 0.33 | 0.36 | ||
| Troponin T type 3 (skeletal, fast) | 0.39 | 0.45 | ||
| Troponin I type 1 (skeletal, slow) | 0.37 | |||
| Prelamin-A/C | 0.27 | 0.44 | ||
| Sus scrofa myotilin | 0.40 | 0.44 | ||
| Sus scrofa tropomyosin 3 | 0.41 | |||
| Troponin I type 3 | 0.39 | 0.42 | 0.45 | |
| Cellular response to stress | ||||
| General transcription factor IIH subunit 4 | 2.13 | |||
| Excision repair cross-complementing rodent repair complementation group 1 | 2.06 | |||
| Heat shock 70 kDa protein 1-like | 2.20 | 2.64 | ||
| mutL homolog 1 | 2.09 | |||
| Growth arrest and DNA-damage-inducible, alpha | 2.04 | |||
| Cyclin-dependent kinase inhibitor 1A | 3.78 | |||
| Sus scrofa myoglobin (MB) | 0.12 | 0.25 | ||
| Chemokine (C-X-C motif) ligand 10 | 2.58 | |||
| Mitogen-activated protein kinase 14 | 3.02 | 2.11 | ||
| Toll-like receptor adaptor molecule 2 | 3.35 | 2.02 | ||
| Cellular response to hormone stimulus | ||||
| Nuclear receptor subfamily 3, group C, member 1 | 0.48 | |||
| Growth hormone receptor | 0.27 | |||
| Activin type I receptor | 0.30 | |||
| Adrenergic, beta-2- receptor | 0.32 | 0.49 | ||
| Interferon gamma receptor 2 | 0.27 | |||
| Folate receptor 2 | 0.47 | 0.44 | ||
| Adiponectin receptor 1 | 0.48 | |||
aGenes shown in boldface were used in qPCR verification
bOnly the fold change of differentially expressed genes related to energy metabolism, muscle structure, and stress response are shown. Values > 1.0 show upregulation, and < 1.0 show downregulation
Significant KEGG pathway analysis
| Pathway name | Gene involved | FDR | Genes | ||
|---|---|---|---|---|---|
| 22PF vs 22AL (up) | |||||
| Up | Metabolism of xenobiotics by cytochrome P450 | 2/53 | 0.0110 | 0.782 | |
| Bile secretion | 2/59 | 0.0136 | 0.782 | ||
| PPAR signaling pathway | 2/64 | 0.0158 | 0.782 | ||
| Down | Dilated cardiomyopathy | 5/41 | 0.0003 | 0.0483 | |
| Phagosome | 6/134 | 0.0003 | 0.0483 | ||
| Antigen processing and presentation | 4/63 | 0.0011 | 0.054 | ||
| 35AL vs 22AL | |||||
| Up | Ribosome | 6/83 | 0.0008 | 0.13 | |
| p53 signaling pathway | 5/60 | 0.0011 | 0.13 | ||
| Adipocytokine signaling pathway | 3/61 | 0.0468 | 1 | ||
| Down | Arginine and proline metabolism | 11/47 | 3.09E-07 | 7.64E-05 | |
| Glycolysis/gluconeogenesis | 9/51 | 4.38E-05 | 0.0024 | ||
| PPAR signaling pathway | 10/64 | 4.92E-05 | 0.0024 | ||
| Phagosome | 14/134 | 0.0002 | 0.0056 | ||
| Endocytosis | 16/179 | 0.0003 | 0.0081 | ||
| Citrate cycle (TCA cycle) | 6/29 | 0.0004 | 0.0081 | ||
| Dilated cardiomyopathy | 10/81 | 0.0004 | 0.0081 | ||
| Fatty acid metabolism | 7/41 | 0.0004 | 0.0081 | ||
| Valine, leucine and isoleucine degradation | 7/44 | 0.0006 | 0.0117 | ||
| Pyruvate metabolism | 6/36 | 0.0012 | 0.0194 | ||
| Leukocyte transendothelial migration | 10/103 | 0.0024 | 0.0354 | ||
| 35AL vs 22PF (up) | |||||
| Up | Adipocytokine signaling pathway | 3/60 | 1.6E-06 | 0.0004 | |
| Herpes simplex infection | 8/157 | 0.0002 | 0.0193 | ||
| Toll-like receptor signaling pathway | 6/87 | 0.0002 | 0.0193 | ||
| Down | Glycolysis/gluconeogenesis | 7/51 | 1.97E-05 | 0.0049 | |
| Citrate cycle (TCA cycle) | 5/29 | 0.0001 | 0.0131 | ||
| Hypertrophic cardiomyopathy (HCM) | 7/76 | 0.0003 | 0.0166 | ||
| Starch and sucrose metabolism | 5/35 | 0.0003 | 0.0166 | ||
| Dilated cardiomyopathy | 7/81 | 0.0004 | 0.0194 | ||
| Arginine and proline metabolism | 5/47 | 0.0011 | 0.0381 | ||
| PPAR signaling pathway | 4/64 | 0.022 | 1.6496 | ||
Fig. 2Correlations between relative abundance of selected transcripts determined by qPCR and gene chips. Vertical axis, relative abundance, normalized to values in pigs fed ad libitum at 22 °C. Correlations are between gene chips and qPCR pairs of data (n = 4 pools of two pigs per treatment)
Fig. 3Western blots for a selection of differentially expressed proteins. Targeted protein DECR1, FABP3, HSPA1L, LPIN1, PFKM, TNNT3, TNNI1, PPARGC-1, MSTN, FASN, and PCK1, with GAPDH as a reference protein. a Representative sample from each treatment fractionated by SDS-PAGE, blotted and then detected with specific antibodies. b Semi-quantification of protein content from scans of band, (n = 4 pools of two pigs per treatment)
Fig. 4TOC graphic of this article